
    
      This is a phase I, randomized, single-blind, placebo controlled, sequential-group design
      study to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of
      AZD7594 after single and multiple ascending doses given once daily by inhalation in healthy
      male Japanese subjects, compared with placebo
    
  